Literature DB >> 28104823

Changing Paradigms in Contrast Nephropathy.

Arnaldo Lopez-Ruiz1, Kiran Chandrashekar2, Luis A Juncos3,4.   

Abstract

Entities:  

Keywords:  AKI; CKD; contrast nephropathy

Mesh:

Substances:

Year:  2017        PMID: 28104823      PMCID: PMC5280036          DOI: 10.1681/ASN.2016121369

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  18 in total

1.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

Review 2.  Risk of iodinated contrast material--induced nephropathy with intravenous administration.

Authors:  Richard W Katzberg; Brendan J Barrett
Journal:  Radiology       Date:  2007-04-19       Impact factor: 11.105

3.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.

Authors:  P A McCullough; R Wolyn; L L Rocher; R N Levin; W W O'Neill
Journal:  Am J Med       Date:  1997-11       Impact factor: 4.965

Review 4.  Contrast-induced nephrotoxicity: clinical landscape.

Authors:  R W Katzberg; C Haller
Journal:  Kidney Int Suppl       Date:  2006-04       Impact factor: 10.545

Review 5.  Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis.

Authors:  Qasim Ali Rao; Jeffrey H Newhouse
Journal:  Radiology       Date:  2006-03-16       Impact factor: 11.105

Review 6.  Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function.

Authors:  Eugenia Nikolsky; Eve D Aymong; George Dangas; Roxana Mehran
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

7.  Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction.

Authors:  H Mehrdad Sadeghi; Gregg W Stone; Cindy L Grines; Roxana Mehran; Simon R Dixon; Alexandra J Lansky; Martin Fahy; David A Cox; Eulogio Garcia; James E Tcheng; John J Griffin; Thomas D Stuckey; Mark Turco; John D Carroll
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

8.  Failure to demonstrate contrast nephrotoxicity.

Authors:  C A Heller; J Knapp; J Halliday; D O'Connell; R F Heller
Journal:  Med J Aust       Date:  1991-09-02       Impact factor: 7.738

9.  Estimating the Risk of Radiocontrast-Associated Nephropathy.

Authors:  Emilee Wilhelm-Leen; Maria E Montez-Rath; Glenn Chertow
Journal:  J Am Soc Nephrol       Date:  2016-09-29       Impact factor: 10.121

10.  Renal function following infusion of radiologic contrast material. A prospective controlled study.

Authors:  B C Cramer; P S Parfrey; T A Hutchinson; D Baran; D M Melanson; R E Ethier; J F Seely
Journal:  Arch Intern Med       Date:  1985-01
View more
  3 in total

1.  Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.

Authors:  Jing Wang; Xiaobo Ai; Li Li; Yanyan Gao; Nina Sun; Changgui Li; Weihong Sun
Journal:  Int Urol Nephrol       Date:  2017-06-27       Impact factor: 2.370

2.  A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents.

Authors:  Huanhuan Zheng; Guolang Wang; Qianqian Cao; Wenkai Ren; Lingyuan Xu; Shuangshan Bu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 3.  Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches.

Authors:  Prit Kusirisin; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  J Transl Med       Date:  2020-10-20       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.